Finzati - Logo
PHR logo

Phreesia, Inc.

PHR • Medical - Healthcare Information Services
$0.00
— 0.00 (0.00%)
EarningsSep 3, 11:08 AM UTC
New financial eventQ2 2027Positive

Phreesia, Inc. has reported Q2 2027 financial results

The latest report is predominantly positive and shows an overall improvement in financial performance. Revenue and profitability advanced at a meaningful pace, while the weaker areas should be reviewed in context. The report may attract increased investor attention and price volatility.

Finzati signal
Positive development
Sep 3, 11:08 AM UTC
Improved
+10.41%
Revenue
Improved
+597.25%
Net income
Improved
+36.49%
Free cash flow
Changed
-25.77%
Cash
Changed
+606.28%
Total debt
What changed
↑Revenue increased 10.4% versus the comparable prior period, indicating stronger top-line growth.
↑Net income increased 597.2%, showing improved profitability.
↑Free cash flow increased 36.5%, strengthening cash generation.
↑Total debt increased 606.3%, which may reduce financial flexibility.
Based on newly processed financial statements and comparable prior-period data.This is informational analysis, not investment advice.
Financial data as of: Jul 31, 2026, 12:00 AM UTCLast earnings update: Sep 3, 2026, 11:08 AM UTCLast profile update: Sep 4, 2026, 12:11 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.00
Change0.00%
Market Cap$686.11M
52W Range7.77 - 30.43
Beta0.84
Gross Margin67.93%
Oper. Margin-1.38%
Profit Margin0.48%
Debt/Eq0.30
Current Ratio1.53
Quick Ratio1.53
Revenue 5Y-20.78%

Investment DNA

How strong this company looks for long-term investors

63
out of 100
Business Quality
Margins, moat, returns
40/100
Financial Strength
Debt, cash, stability
72/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
60/100
Why this score▼
Positive revenue growth · 17.1%Positive free cash flow · 1.13Manageable debt level · 0.3Healthy liquidity · 1.53Expensive earnings multiple · 347.91

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-09-04
Low
$10.00
Mean
$12.33
Median
$12.00
High
$16.00

Company Overview

IPO: 7/18/2019
Industry: Medical - Healthcare Information Services
P/B i: 2.38
Debt / Equity i: 0.30
Operating Margin: -1.38%
Net Margin: 0.48%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.30
Current Ratio: 1.53
Quick Ratio: 1.53
Status: Good

Insider Transactions

Recent executive and insider activity

Gandhi Balaji
Transaction: 09/01/2026
BUY
Change
+192,000
Price
Not reported
Filing
09/03/2026
Type
BUY
Hoffman Allison C
Transaction: 09/01/2026
BUY
Change
+108,000
Price
Not reported
Filing
09/03/2026
Type
BUY
Hui Yvonne
Transaction: 09/01/2026
BUY
Change
+43,000
Price
Not reported
Filing
09/03/2026
Type
BUY